Peptides derived from exogenous proteins are presented by both MHC class I and II. Despite extensive study, the features of the endocytic pathway that mediate cross-presentation of exogenous antigens on MHC class I are not entirely understood and difficult to generalize to all proteins. Here, we used dendritic cells and macrophages to examine MHC class I and II presentation of hen egg-white lysozyme (HEL) in different forms, soluble and liposome encapsulated. Soluble HEL or HEL targeted to a late endosomal compartment only allowed for MHC class II presentation, in a process that was blocked by chloroquine and a cathepsin S (CatS) inhibitor; brefeldin A (BFA) also blocked presentation, indicating a requirement for nascent MHC class II. In contrast, liposome-encapsulated HEL targeted to early endosomes entered the MHC class I and II presentation pathways. Cross-presentation of HEL in early endosomal liposomes had several unique features: it was markedly increased by BFA and by blockade of the proteasome or CatS activity, it occurred independently of the transporter associated with antigen processing but required an MHC class I surfacestabilizing peptide, and it was inhibited by chloroquine. Remarkably, chloroquine facilitated MHC class I cross-presentation of soluble HEL and HEL in late endosomal liposomes. Altogether, MHC class I and II presentation of HEL occurred through pathways having distinct molecular and proteolytic requirements. Moreover, MHC class I sampled antigenic peptides from various points along the endocytic route.cross-presentation ͉ endosome ͉ liposomes D endritic cells (DCs) and macrophages (Ms) present peptides derived from exogenous antigens on MHC class I and II (1). The subcellular localization of the antigen processing and MHC loading steps determines the molecular and proteolytic requirements for generation of a particular peptide (2, 3). In the MHC class II pathway, there is general agreement on the roles for protein synthesis, invariant chain, DM, and endosomal acidification for protein presentation, which differ from those of peptide presentation (1). Presentation by MHC class I (i.e., cross-presentation) involves unique antigen transport through the endocytic route that may or may not engage the classical MHC class I pathway (4). For example, the generation of K b -SIINFEKL complexes from ovalbumin (Ova), the most frequently tested protein, required specific components of the MHC class I processing machinery contingent on the form of antigen and the nature of the presenting cell (5, 6); some forms of Ova entered the cytosol for proteasomal processing (6-10), whereas others did not (5, 11). Although several recent reports described endosomes/phagosomes facilitating both MHC class I and II presentation, it is unclear if these compartments are unique or even extant (12).Previous studies by our laboratory demonstrated that protein encapsulation in liposomes enabled antigen targeting to specific endosomal compartments for processing and presentation on MHC class I and II (13,14). Liposomes...